NCT03335592

Cost of Off-label Antibiotics in Osteoarticular Infections

Cost of Off-label Antibiotics in Osteoarticular Infections: Prospective Study Over 2 Years in a Reference Center for the Management of Complex Bone and Joint Infection

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (actual)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Due to the emergence of multidrug-resistant micro-organisms in patients with bone and joint infection (BJI), the prescription of off-labeled antibiotics seem to be more and more common as part of routine care. These new antibiotics are, however, more expensive, and there are no precise data in France regarding the volume and cost of such off-label prescriptions in hospital, in the post-acute care structures, and in the outpatient setting. The objective of this study is to estimate the cost of using these antibiotics over 2 years for patients in a reference center for the management of complex bone and joint infection (CRIOAc)

Conditions

• Bone Infection
• Joint Infection

Timeline

• Start date: 2017-01-01
• Primary completion: 2021-04-01
• Completion: 2022-04-01
• First posted: 2017-11-07
• Last updated: 2024-02-28

Locations

1 site across 1 country: France